BusinessAdvanced Accelerator Applications Announces Revised EMA Review Timeline for Lutathera®By Nasdaq OMXSep 20, 2016, 11:01 AM UTC
BusinessAdvanced Accelerator Applications Announces Positive EMA Opinion on Application for SomaKit TOC Kit for Radiopharmaceutical Preparation of Gallium (Ga 68) Edotreotide for Gastroenteropancreatic Neuroendocrine Tumor DetectionBy Nasdaq OMXSep 16, 2016, 11:00 AM UTC
BusinessAdvanced Accelerator Applications Announces Two Phase II Studies Evaluating 99MrhAnnexin V-128 Imaging in Cardiovascular and Cardio-Oncology Indications at University of Ottawa Heart Institute and Ottawa HospitalBy Nasdaq OMXSep 6, 2016, 11:00 AM UTC
BusinessAdvanced Accelerator Applications Reports 24.4% Sales Growth in the Second Quarter of 2016By Nasdaq OMXAug 31, 2016, 11:00 AM UTC
BusinessAdvanced Accelerator Applications Provides Lutathera UpdateBy Nasdaq OMXMar 23, 2016, 11:00 AM UTC
BusinessAdvanced Accelerator Applications Provides Update on Lutathera and SomakitBy Nasdaq OMXFeb 25, 2016, 12:00 PM UTC
